Invention Grant
US08394839B2 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution 有权
通过选择性同位素替代,合理改善异烟肼和乙硫异烟酰胺衍生物和活性

  • Patent Title: Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution
  • Patent Title (中): 通过选择性同位素替代,合理改善异烟肼和乙硫异烟酰胺衍生物和活性
  • Application No.: US12674188
    Application Date: 2008-08-20
  • Publication No.: US08394839B2
    Publication Date: 2013-03-12
  • Inventor: Graham TimminsVojo P Deretic
  • Applicant: Graham TimminsVojo P Deretic
  • Applicant Address: US NM Albuquerque US MD Baltimore
  • Assignee: STC.UNM,The John Hopkins University
  • Current Assignee: STC.UNM,The John Hopkins University
  • Current Assignee Address: US NM Albuquerque US MD Baltimore
  • Agent Henry D. Coleman; R. Neil Sudol; William J. Sapone
  • International Application: PCT/US2008/009909 WO 20080820
  • International Announcement: WO2009/025820 WO 20090226
  • Main IPC: A61K31/4409
  • IPC: A61K31/4409 C07D213/86
Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution
Abstract:
The present invention relates to the use of isotopically labeled derivatives of isoniazid, ethionamide and related compounds as effective therapy for the treatment of mycobacterial diseases, including Mycobacterium tuberculosis.
Information query
Patent Agency Ranking
0/0